[Portal hypertension. Current status of multidisciplinary management].
Mercado
M A
MA
Departamento de Cirugía, Instituto Nacional de la Nutrición Salvador Zubirán.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004932:Esophageal and Gastric Varices / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D004945:Esophagoscopy; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D006975:Hypertension, Portal / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D008026:Ligation; D008111:Liver Function Tests; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use; D015911:Sclerotherapy; D013164:Splenorenal Shunt, Surgical; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D005765:Gastrointestinal Agents; D014662:Vasoconstrictor Agents; D015282:Octreotide